Atara Biotherapeutics (ATRA) Cost of Revenue (2023 - 2026)
Atara Biotherapeutics (ATRA) posted Cost of Revenue of $124000.0 for Q1 2026, up 19.23% on a QoQ basis from $104000.0 in Q4 2025, and down 99.39% year-over-year from $20.4 million in Q1 2025.
Atara Biotherapeutics (ATRA) Cost of Revenue (2023 - 2026) Analysis & Trends
Atara Biotherapeutics' Cost of Revenue history runs 4 years deep, the most recent figure standing at $124000.0 for Q1 2026.
- Quarterly Cost of Revenue fell 99.39% year-over-year to $124000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $897000.0 (down 97.73% YoY) and the FY2025 annual result came in at $21.2 million, up 0.97% from the prior year.
- Cost of Revenue was $124000.0 for Q1 2026 at Atara Biotherapeutics, up from $104000.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $20.4 million in Q1 2025 and bottomed at $104000.0 in Q4 2025.
- A 4-year average of $3.9 million and a median of $2.6 million in 2023 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2025 — Cost of Revenue surged 929.67% — and 2026, when it slumped 99.39%.
- Atara Biotherapeutics' Cost of Revenue stood at $3.2 million in 2023, then jumped by 115.03% to $6.8 million in 2024, then sank by 98.47% to $104000.0 in 2025, then rose by 19.23% to $124000.0 in 2026.
- Business Quant data shows ATRA's Cost of Revenue at $124000.0 in Q1 2026, $104000.0 in Q4 2025, and $115000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 167.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 392.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 296.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 145.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | 124,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 124,000.00 |
| Mar 31, 2026 | 124,000.00 |
| Dec 31, 2025 | 104,000.00 |
| Dec 31, 2025 | 104,000.00 |
| Sep 30, 2025 | 115,000.00 |
| Sep 30, 2025 | 115,000.00 |
| Jun 30, 2025 | 554,000.00 |
| Jun 30, 2025 | 554,000.00 |
| Mar 31, 2025 | 20.44 Mn |
| Mar 31, 2025 | 20.44 Mn |
| Dec 31, 2024 | 6.80 Mn |
| Dec 31, 2024 | 6.80 Mn |
| Sep 30, 2024 | 7.60 Mn |
| Sep 30, 2024 | 7.60 Mn |
| Jun 30, 2024 | 4.63 Mn |
| Jun 30, 2024 | 4.63 Mn |
| Mar 31, 2024 | 1.99 Mn |
| Mar 31, 2024 | 1.99 Mn |
| Dec 31, 2023 | 3.16 Mn |
| Dec 31, 2023 | 3.16 Mn |